We are live on ! Find out more
DC

Defender Capital Portfolio holdings

AUM $308M
1-Year Est. Return 4.52%
This Fund
S&P 500
This Quarter Est. Return
-6.09%
1 Year Est. Return
+4.52%
3 Year Est. Return
+83.48%
5 Year Est. Return
+78.82%
10 Year Est. Return
AUM
$288M
AUM Growth
-$24.4M
Cap. Flow
-$1.43M
Cap. Flow %
-0.5%
Top 10 Hldgs %
87.34%
Holding
45
New
2
Increased
13
Reduced
9
Closed
9

Sector Composition

1 Healthcare 34.21%
2 Technology 18.68%
3 Financials 14.24%
4 Consumer Staples 9.06%
5 Industrials 6.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VGSH icon
1
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
$45.8M 15.91%
772,246
+58,550
+8% +$3.52M
DHR icon
2
Danaher
DHR
$144B
$42.4M 14.74%
162,152
-6,746
-4% -$1.69M
BRK.B icon
3
Berkshire Hathaway Class B
BRK.B
$1.06T
$40.5M 14.07%
115,711
-24,151
-17% -$7.81M
STAA icon
4
STAAR Surgical
STAA
$1.32B
$31.1M 10.8%
387,857
+120,065
+45% +$8.94M
FTV icon
5
Fortive
FTV
$18.8B
$28.4M 9.89%
611,237
+12,374
+2% +$612K
AXON
6
Axon Enterprise
AXON
$41.1B
$15M 5.22%
107,810
+4,230
+4% +$580K
TDY icon
7
Teledyne Technologies
TDY
$29.4B
$13.4M 4.66%
28,480
+16,129
+131% +$6.94M
COST icon
8
Costco
COST
$417B
$13.4M 4.64%
23,195
-12,423
-35% -$6.52M
MNST icon
9
Monster Beverage
MNST
$95.4B
$12.4M 4.31%
306,038
-162,620
-35% -$6.82M
ENOV icon
10
Enovis
ENOV
$1.56B
$8.9M 3.1%
128,178
+3,065
+2% +$218K
LCTX icon
11
Lineage Cell Therapeutics
LCTX
$289M
$7.98M 2.78%
5,006,185
+8,315
+0.2% +$12.9K
INTC icon
12
Intel
INTC
$478B
$7.72M 2.68%
154,565
+900
+0.6% +$44.6K
IMDX
13
Insight Molecular Diagnostics
IMDX
$153M
$4M 1.39%
128,107
+17,267
+16% +$552K
BE icon
14
Bloom Energy
BE
$61.1B
$3.6M 1.25%
151,000
+131,000
+655% +$2.56M
PLTR icon
15
Palantir
PLTR
$317B
$2.17M 0.75%
153,065
+30,755
+25% +$410K
LFCR icon
16
Lifecore Biomedical
LFCR
$176M
$1.39M 0.48%
121,450
-5,000
-4% -$55.7K
AAPL icon
17
Apple
AAPL
$4.9T
$1.14M 0.4%
6,503
-1,511
-19% -$254K
AMZN icon
18
Amazon
AMZN
$2.66T
$808K 0.28%
4,960
KMI icon
19
Kinder Morgan
KMI
$71.9B
$775K 0.27%
41,000
ANIP icon
20
ANI Pharmaceuticals
ANIP
$1.8B
$675K 0.23%
24,000
+5,000
+26% +$186K
CGEN icon
21
Compugen
CGEN
$224M
$674K 0.23%
209,272
-2,250
-1% -$7.6K
AMWL icon
22
American Well
AMWL
$221M
$669K 0.23%
7,076
-435
-6% -$36.7K
MSFT icon
23
Microsoft
MSFT
$2.93T
$643K 0.22%
2,085
+20
+1% +$6.02K
MIR icon
24
Mirion Technologies
MIR
$3.91B
$628K 0.22%
60,000
IVV icon
25
iShares Core S&P 500 ETF
IVV
$881B
$535K 0.19%
1,179

Similar funds

Defender Capital's Q1 2022 Portfolio in Review

As of Q1 2022, Defender Capital held 45 positions worth $288M, down 7.8% from $312M the previous quarter. Its ten largest holdings account for 87% of the portfolio.

Defender Capital's Q1 2022 filing shows 2 new, 13 increased, 9 reduced and 9 closed positions. Its largest new stake was iShares Russell 2000 ETF: 2,000 shares worth $411K. The largest sale was Berkshire Hathaway Class B, an estimated $7.81M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 34% a quarter earlier, followed by Technology and Financials.

  • Defender Capital's largest Q1 2022 buy was iShares Russell 2000 ETF: 2,000 shares worth $411K.
  • Defender Capital added most to STAAR Surgical in Q1 2022, an estimated $8.94M increase.
  • Defender Capital's biggest Q1 2022 reduction was Berkshire Hathaway Class B, cutting an estimated $7.81M.
  • Defender Capital fully exited Pfizer in Q1 2022, selling an estimated $764K.
  • Defender Capital's ten largest holdings make up 87% of its $288M portfolio in Q1 2022.
  • Defender Capital opened 2 new positions and closed 9 in Q1 2022.
  • Defender Capital's portfolio value fell 7.8% quarter-over-quarter to $288M.

Based on Defender Capital's 13F filing for Q1 2022, filed 22 Apr 2022.